Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Researchers UC San Diego discover that persistency allows value signals to be most effectively represented, or “coded,” across different areas of the brain.
CellSight researchers at the University of Colorado School of Medicine are offering the first evidence connecting drusen formation, or yellowish deposits that accumulate under the retina, with extracellular vesicles and age-related macular degeneration.
Researchers have uncovered the mechanism of vision loss in Usher syndrome, yielding additional drug targets for eventual development of better therapies.
The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound, can safely reduce oxidative stress and inflammation in the retina, both early, major contributors to diabetic retinopathy.
The National Eye Institute has released a new strategic plan. 2021 Vision for the Future charts the next five years of NEI’s mission: to eliminate vision loss and improve quality of life through vision research.
Researchers at the Max Planck Florida Institute for Neuroscience (MPFI) have uncovered a surprisingly complex yet precisely ordered map of visual space in area V2 of the cortex.
Scientists at the John A. Moran Eye Center at the University of Utah have discovered a new type of nerve cell, or neuron, in the retina. The newly identified Campana cell could play a role in visual signal processing.
An antidepressant best known as Prozac could offer the first treatment for the leading cause of blindness among people over 50, new research from the University of Virginia School of Medicine suggests.
